Lakewood-Amedex Biotherapeutics
LABT
#11175
Rank
NZ$3.65 M
Marketcap
NZ$1.54
Share price
1.42%
Change (1 day)
N/A
Change (1 year)
Categories

Revenue for Lakewood-Amedex Biotherapeutics (LABT)

Revenue in 2026 (TTM): N/A

In 2025 the company made a revenue of N/A.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Lakewood-Amedex Biotherapeutics from 2025 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) N/A
2025 N/A